OpenAlex
PricingAboutJobs
Log inGet started
Work

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

HTML

Year: 2013
Type: article
Study design: Clinical Trial
Source: Journal of the American College of Cardiology
DOI: 10.1016/j.jacc.2013.03.037
Authors: Paul A. Gurbel, Kevin P. Bliden, Douglas K. Logan, Dean J. Kereiakes, Kenneth C. Lasseter, Alex White, Dominick J. Angiolillo, Thomas D. Nolin, Jen-Fue Maa, William L. Bailey, Joseph A. Jakubowski, Clement K. Ojeh, Young-Hoon Jeong, Udaya S. Tantry, Brian A. Baker
Institutions: Sinai Hospital, Medpace (United States), Christ Hospital, Clinical Pharmacology of Miami, University of Florida, University of Florida Health Science Center, University of Pittsburgh, Daiichi Sankyo (United States), Eli Lilly (United States)
Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: smoking, clopidogrel, prasugrel, pharmacokinetics, pharmacodynamics, platelet aggregation inhibition, P2Y12 inhibition, CYP2C19 genotype, CYP1A2 activity, clopidogrel metabolite, coronary artery disease, platelet reactivity index, aspirin therapy, antiplatelet therapy
SDG: Good health and well-being

Open Access status: bronze

Funder: Eli Lilly and Company
OpenAlex ID: W36049561
FWCI: 15.13
Cites: 18
Cited by: 155
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security